Laterza, Lucrezia
 Distribuzione geografica
Continente #
EU - Europa 1.635
NA - Nord America 1.439
AS - Asia 353
AF - Africa 7
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
Totale 3.444
Nazione #
US - Stati Uniti d'America 1.429
DE - Germania 447
IT - Italia 321
SE - Svezia 287
CN - Cina 174
PL - Polonia 161
UA - Ucraina 99
IE - Irlanda 88
FR - Francia 84
SG - Singapore 84
GB - Regno Unito 48
FI - Finlandia 33
IN - India 28
RU - Federazione Russa 20
TR - Turchia 14
BE - Belgio 13
IR - Iran 10
JP - Giappone 9
KR - Corea 9
NL - Olanda 8
CZ - Repubblica Ceca 7
IQ - Iraq 7
CA - Canada 6
CI - Costa d'Avorio 6
PH - Filippine 6
ES - Italia 5
HK - Hong Kong 4
RO - Romania 4
AU - Australia 3
BR - Brasile 3
EU - Europa 3
MX - Messico 3
CH - Svizzera 2
MD - Moldavia 2
PK - Pakistan 2
PT - Portogallo 2
BN - Brunei Darussalam 1
CY - Cipro 1
EG - Egitto 1
GR - Grecia 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
LT - Lituania 1
ME - Montenegro 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
SA - Arabia Saudita 1
VN - Vietnam 1
Totale 3.444
Città #
Chandler 336
Ashburn 148
Warsaw 143
Dublin 85
Ann Arbor 68
Jacksonville 66
New York 65
San Mateo 62
Cattolica 54
Singapore 53
Milan 48
Rome 48
Wilmington 39
Nanjing 34
Boston 33
Woodbridge 30
Dearborn 27
Boardman 26
Fairfield 25
Marseille 25
Beijing 24
Nürnberg 24
Lawrence 22
Moscow 19
Princeton 18
Houston 17
Seattle 17
Munich 16
Kraków 15
Redwood City 14
Bremen 13
Lancaster 13
Izmir 12
Monza 11
Mountain View 11
Shenyang 11
Brussels 10
Fremont 10
Helsinki 10
Hangzhou 9
Hebei 9
Nanchang 9
Naples 9
Seoul 9
Kish 8
Cambridge 7
Paris 7
Abidjan 6
Andover 6
Changsha 6
Jiaxing 6
Redmond 6
San Diego 6
Washington 6
Groningen 5
Los Angeles 5
Pune 5
Tianjin 5
Arezzo 4
Augusta 4
Baghdad 4
Brno 4
Busto Arsizio 4
Cagayan de Oro 4
Jinan 4
Kunming 4
Leawood 4
London 4
Macerata 4
Norwalk 4
Shanghai 4
Verona 4
Zhengzhou 4
Amsterdam 3
Baronissi 3
Bologna 3
Detroit 3
Edinburgh 3
Querétaro City 3
San Francisco 3
Springfield 3
Tokyo 3
Trieste 3
Ancona 2
Ankara 2
Barnet 2
Bentivoglio 2
Berlin 2
Cagliari 2
Cassino 2
Catania 2
Chengdu 2
Chicago 2
Cluj-Napoca 2
Duhok 2
Faisalabad 2
Falls Church 2
Fano 2
Guangzhou 2
Hong Kong 2
Totale 1.955
Nome #
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 291
Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases 150
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 128
13C-octanoic acid breath test to study gastric emptying time 126
Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterography 118
Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterography 112
Irritable bowel syndrome and nickel allergy: What is the role of the low nickel diet? 99
Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication 94
Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease 93
Tricks for interpreting and making a good report on hydrogen and 13C breath tests 91
Gastrointestinal motility disorder assessment in systemic sclerosis 90
Erratum to: Binge Drinking among adolescents is related to the development of Alcohol Use Disorders: results from a Cross-Sectional Study (Scientific Reports, (2018), 8, 1, (12624), 10.1038/s41598-018-29311-y) 90
Gut microbial flora, prebiotics and probiotics in IBD: their current usage and utility 88
Origin of celiac disease: How old are predisposing haplotypes? 86
Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome 86
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 83
Role of yeasts in healthy and impaired gut microbiota: the gut mycome 81
Binge Drinking among adolescents is related to the development of Alcohol Use Disorders: results from a Cross-Sectional Study 79
Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome? 77
Gastrointestinal motility disorder assessment in systemic sclerosis 74
Pancreatic function assessment 74
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 73
Secretome modulation of Caco-2 cell line induced by a multi-strain probiotic 68
Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn's Disease 63
Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease 62
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 58
Epidemiology of inflammatory bowel disease in the Republic of San Marino: The “EPIMICI – San Marino” study 56
Eluxadoline for the treatment of diarrhoea-predominant irritable bowel syndrome 55
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 52
SECRETOME MODULATION OF CACO2 CELL LINE INDUCED BY A MULTI-STRAIN PROBIOTIC 51
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 48
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE 47
Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients undergoing anti-TNFα therapy 47
Evaluation of tolerability and major factors affecting the adherence to probiotic therapy in patients with irritable bowel syndrome: a prospective, observational, real-life study 44
Gut and reproductive tract microbiota adaptation during pregnancy: New insights for pregnancy-related complications and therapy 42
Diet-Induced Alterations in Gut Microbiota Composition and Function 42
Gut microbiota during dietary restrictions: New insights in non-communicable diseases 38
Impact of the Trophic Effects of the Secretome from a Multistrain Probiotic Preparation on the Intestinal Epithelia 36
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 32
Bariatric procedures and microbiota: patient selection and outcome prediction 31
The Microbiota-Gut-Brain Axis: Psychoneuroimmunological Insights 30
Risk factors for gastric cancer: is it time to discard PPIs? 30
Effect of a multistrain probiotic on leaky gut in patients with diarrhea-predominant irritable bowel syndrome (IBS-D): a pilot study 28
Onset of ulcerative colitis after thyrotoxicosis: a case report and review of the literature 28
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis 27
Radiomics could predict surgery at 10 years in Crohn's disease 25
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19 19
Popular diets and nutritional assessment in the management of irritable bowel syndrome in inflammatory bowel disease: an overview of current evidence 17
Gut and reproductive tract microbiota adaptation during pregnancy: New insights for pregnancy-related complications and therapy 17
The Microbiota-Gut-Brain Axis: Psychoneuroimmunological Insights 15
Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle Together 13
Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease 12
Extracellular Vesicles: Novel Potential Therapeutic Agents in Inflammatory Bowel Diseases 11
Cytomegalovirus Infection: An Underrated Target in Inflammatory Bowel Disease Treatment 11
1L- vs. 4L-Polyethylene glycol for bowel preparation before colonoscopy among inpatients: A propensity score-matching analysis 10
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study 8
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients 8
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 8
Systematic review with meta-analysis: the appropriateness of colonoscopy increases the probability of relevant findings and cancer while reducing unnecessary exams 8
Factors That Affect Adequacy of Colon Cleansing for Colonoscopy in Hospitalized Patients 8
Clinical value of alarm features for colorectal cancer: A meta-analysis 7
How to identify patients who are less likely to have metachronous neoplasms after a colon cancer: A predictive model 6
Clinical value of alarm features for colorectal cancer: A meta-analysis 5
1L- vs. 4L-Polyethylene glycol for bowel preparation before colonoscopy among inpatients: A propensity score-matching analysis 5
Systematic review with meta-analysis: the appropriateness of colonoscopy increases the probability of relevant findings and cancer while reducing unnecessary exams 4
The diagnostic yield of colonoscopy in hospitalized patients. An observational multicenter prospective study 4
Factors That Affect Adequacy of Colon Cleansing for Colonoscopy in Hospitalized Patients 3
The diagnostic yield of colonoscopy in hospitalized patients. An observational multicenter prospective study 3
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission 3
Higher adenoma recurrence rate after left- versus right-sided colectomy for colon cancer 2
Totale 3.530
Categoria #
all - tutte 15.214
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.214


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201919 0 0 0 0 0 0 0 0 0 0 0 19
2019/2020445 93 22 32 23 30 33 51 10 26 29 74 22
2020/2021281 14 30 6 26 39 17 32 6 30 16 57 8
2021/2022364 15 25 5 14 22 16 6 71 14 51 56 69
2022/2023930 108 126 79 136 58 101 55 79 93 36 40 19
2023/2024728 25 125 51 46 42 108 50 19 46 34 82 100
Totale 3.530